Healthcare Triangle, Inc.
HCTI
$8.53
$1.3017.98%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -21.88% | -45.90% | -58.90% | -64.77% | -55.75% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -21.88% | -45.90% | -58.90% | -64.77% | -55.75% |
| Cost of Revenue | -9.34% | -40.03% | -57.29% | -66.68% | -59.17% |
| Gross Profit | -59.25% | -65.02% | -64.42% | -57.36% | -41.03% |
| SG&A Expenses | 13.66% | -23.48% | -35.68% | -39.14% | -39.62% |
| Depreciation & Amortization | -175.97% | -117.60% | -70.28% | -43.23% | -82.08% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -8.27% | -37.85% | -50.78% | -58.02% | -57.79% |
| Operating Income | -49.32% | -3.51% | 1.07% | 20.53% | 64.70% |
| Income Before Tax | -0.45% | 18.95% | 20.04% | 31.08% | 46.83% |
| Income Tax Expenses | -60.00% | -50.00% | -56.25% | -80.00% | -75.00% |
| Earnings from Continuing Operations | -0.35% | 19.00% | 20.12% | 31.28% | 46.93% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -0.35% | 19.00% | 20.12% | 31.28% | 46.93% |
| EBIT | -49.32% | -3.51% | 1.07% | 20.53% | 64.70% |
| EBITDA | -382.67% | -294.48% | -254.21% | -380.66% | 125.19% |
| EPS Basic | -- | -- | -- | -- | -- |
| Normalized Basic EPS | -- | -- | -- | -- | -- |
| EPS Diluted | -- | -- | -- | -- | -- |
| Normalized Diluted EPS | -- | -- | -- | -- | -- |
| Average Basic Shares Outstanding | -- | -- | -- | -- | -- |
| Average Diluted Shares Outstanding | -- | -- | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |